Cognition Therapeutics, Inc.
CGTX
$1.20
$0.021.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.19% | 26.79% | 20.59% | -8.14% | 21.08% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 35.56% | -36.62% | 1.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.56% | -15.94% | 5.97% | 9.74% | -40.40% |
| Change in Net Operating Assets | 57.52% | -403.96% | 121.15% | -77.12% | -154.01% |
| Cash from Operations | 39.18% | -0.50% | 43.07% | -17.84% | -22.35% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -80.49% | 65.83% | -1.69% | 39.49% | -5.41% |
| Issuance of Common Stock | -91.17% | 3,776.17% | -39.93% | -88.69% | -- |
| Repurchase of Common Stock | -113.89% | -620.00% | 89.13% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -200.00% |
| Cash from Financing | -98.22% | 4,410.24% | -41.98% | -88.61% | 3,359.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.99% | 680.29% | 43.24% | -386.22% | 145.97% |